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p53 is a tumor suppressor and the p53 dynamics displays stimulus dependent patterns. Recent
evidence suggests a bimodal p53 switch in cell fate decision. However, no theoretical studies have
been proposed to investigate bimodal p53 induction. Here we constructed a model and showed that
MDM2–p53 mRNA binding might contribute to bimodal p53 switch through an intrinsic positive
feedback loop. Lower damage favored pulsing while monotonic increasing was generated with
higher damage. Bimodal p53 dynamics was largely inﬂuenced by cellular MDM2 and elevated p53/
MDM2 ratios with increasing etoposide favor mono-ubiquitination. Our model replicated recent
experiments and provided potential insights into dynamic mechanisms of bimodal switch.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Living organisms are constantly confronted with intrinsic and
extrinsic damaging signals. In particular, DNA damage which
may compromise the genomic integrity is the most detrimental
threats to cell survival [1]. In mammalian cells, the p53 signaling
pathway which can integrate upstream damaging signals and ini-
tiate appropriate downstream cellular responses plays critical roles
in DNA damage responses in order to maintain the genomic integ-
rity [2,3]. When damage level is less severe, the p53 network can
trigger moderate responses such as cell cycle arrest and supports
DNA repair. Alternatively, it will allow damaged cells to commit
irreversible programmed cell death when DNA damage is irrepara-
ble [3,4].
Digital or sustained pulses are regarded as the principal dynam-
ics in response to DNA damaging agents such as c-irradiation
which can induce DNA double strand breaks at individual cells
[5,6]. p53 upregulates MDM2 which functions as an E3-ubiquitin
ligase and targets p53 for proteasome-mediated degradation [7].
Meanwhile, another negative feedback loop which involves p53
induced WIP1 expression is also indispensable for generating
sustained pulses [8]. In oscillation or pulsing mode, apoptotic
mediators or alternatively functional forms of p53 are graduallyaccumulated as the number of p53 pulse increases and then the
irreversible cell fate is determined by perturbing a downstream
switch above the threshold level through the p53 induced media-
tors [9–16]. Recently, however, it was found that different DNA
damaging stresses can evoke different p53 dynamics thus raising
new possibilities of ‘non-oscillating’ dynamical patterns [17]. A
few other theoretical studies evaluated the possibilities of non-
pulsing or bistable p53 dynamics and the cell fate decision was pri-
marily ascribed to the bifurcating properties of bistability [18–20].
Noticeably, these theoretical studies mainly focused on transient
DNA damage. The direct link between the p53 dynamics and cell
fate remains to be deﬁned experimentally.
More recently, Chen et al. found that in response to sustained
DNA damage induced by etoposide, the dynamics of p53 bifurcates
with different damage levels [21]. Low levels of damage primarily
induce periodic p53 pulses and cells undergo cell cycle arrest.
Alternatively, p53 may exhibit monotonic increase when damage
level is high and cells enter apoptotic program. The ‘bimodal
switch of p53 dynamics’ generated by different damage doses
can per se determine cell fate [21]. Therefore, theoretical investiga-
tion is strongly required to obtain more quantitative understand-
ing of the bimodal p53 dynamics.
In current study, we constructed a mathematical model to
quantitatively describe the bimodal dynamics of p53. We found
that in addition to two core negative feedback loops, a recently
identiﬁed interaction between p53 mRNA and Ser395 phosphory-
lated MDM2 (MDM2p) is needed to generate bimodal p53
Fig. 2. Bimodal switch of p53 dynamics under low and high etoposide treatment.
Total p53 was in units of lM. Undamped pulses and monotonic increasing patterns
are shown under 1 lM and 100 lM etoposide treatment, respectively.
Fig. 3. Stochastic simulation unravels bimodal p53 dynamics. The inset plot is an
enlarged representation of sustained pulses. Sustained pulses were generated by
treating cells with 1 lM etoposide (black and grey curves). Monotonic increasing
pattern was obtained by setting etoposide = 100 lM (colored curves).
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damage, most cells exhibit sustained pulses with variable ampli-
tude and period. As DNA damage increases, more cells showmono-
tonic p53 increases in their maximum levels. Under mild DNA
damage, more than 90% cells change their dynamics from oscilla-
tion to monotonic increases if MDM2 expression is lowered. We
also showed that the ratio between p53 and MDM2 is signiﬁcantly
elevated with increased DNA damage thus implying that p53
mono-ubiquitination might be favored under strong DNA damage
in which cytoplasmic p53 is substantially accumulated. Taken to-
gether, our theoretical results provide potential insights into the
bimodal dynamics of p53.
2. Results
2.1. The interaction between p53mRNA and phosphorylated MDM2
might contribute to bimodal p53 induction
The schematic representation of our model is shown in Fig. 1. To
identify the role of the newly discovered interactions between p53
mRNA and phosphorylated MDM2 (MDM2p), the parameters rf, rb
and rcomplex were all set to zero. We found that increasing ETS
doses (Fig. S1, 1–100 lM: from dark blue to light blue curves)
did not dramatically raise the level of cellular p53. However, when
the interactive effect was considered, the system showed periodic
and undamped pulsing under 1 lM etoposide treatment (see Fig. 2
and Fig. S1). In addition, we found that the systematic p53 levels
were signiﬁcantly elevated with 100 lM ETS treatment (Fig. 2).
The upregulation of p53 levels reached around 10 fold during a
25-hour simulation. Chen et al. termed the differential p53 induc-
tion under different etoposide doses as ‘bimodal switch of p53
dynamics’ [21]. Therefore, under different ETS doses, our model
showed that the systematic p53 indeed exhibited bimodal dynam-
ics (Fig. 2). There results suggested that the p53 mRNA–MDM2p
interaction might contribute to bimodal p53 dynamics at least in
our current model.
2.2. Dynamic properties of bimodal p53 induction
We then simulated the system in a stochastic manner. The bio-
chemical parameters were also slightly varied to incorporate
extrinsic noises. We found that the bimodal p53 dynamics could
be reproduced under different ETS doses (Fig. 3). The dynamics
of p53 showed signiﬁcant variations irrespective of the exactFig. 1. Schematic representation of our model. Species in italics denote mRNA, and
U represents degradation. Thick arrows denote newly added reactions compared to
our original model.dynamical patterns (see Fig. 3, colored curves: ETS = 100 lM and
the inset: ETS = 1 lM). Eliminating the interaction between
p53mRNA and MDM2 also annihilated the bimodal dynamics in
stochastic simulations (data not shown). Therefore, the dynamics
of p53 was shifted from periodic pulsing to monotonic behavior
as etoposide doses increased in stochastic simulation and these
simulation results were consistent with Chen et al.’ observations
[21].
Next, we set out to identify the cell-to-cell variations. 200 runs
for each etoposide dose were taken and the dynamical trajectories
were classiﬁed as either pulsing or monotonic increasing. We
found that as etoposide doses increased, the fraction of cells that
exhibited periodic pulses decreased while the monotonic fractions
became more evident (Fig. 4, white bars). For ETS doses not more
than 5 lM, the fraction of oscillating p53 was more than 60%Fig. 4. Heterogeneity in bimodal p53 dynamics. For each etoposide dose, 200
stochastic runs were performed and then classiﬁed as described in materials and
methods. White bars denote pulsing fractions while black bars show monotonic
increasing fractions.
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increasing dynamics of p53 (Fig. 4, black bars). Therefore, large cell
to cell variation did exist in the dynamics of p53 under stressed
conditions.
We further investigated the stochasticity in terms of the pulsing
characteristics. Large variations in amplitude and period became
evident independent of the doses (Fig. 5A and C). The CVs for
amplitude also varied signiﬁcantly implying strong stochasticity
(Fig. 5B). Meanwhile, the pulsing period also demonstrated sub-
stantial variations with varying CVs (Fig. 5D). The CV for amplitude
could reach around 0.7 while the CV for period could be more than
0.4 (Fig. 5B and D). Recently, Kracikova et al. and Chen et al. dem-
onstrated that p53 target gene expression is proportional to p53
induction and p53 level per se is a determinant to cell fate
[21,22]. Therefore, we assumed that apoptosis can be induced if a
certain threshold for p53 level is surmounted. We calculated the
time integration of total p53 levels and obtained the time at which
the integrated value exceeded a threshold (2  107). We assumed
that if one cell exceeded the threshold at speciﬁc time, it would un-
dergo apoptosis. 200 trajectories for each dose were investigated
and the survival rate was shown in Fig. S2. We found that as the
dose of etoposide increased, the cellular proﬁle gradually shifted
from survival to apoptosis (Fig. S2). Meanwhile, the cell death re-
sponses became more and more saturated with increasing doses.
These simulation results were qualitatively consistent with Chen
et al.’s experiments [21]. These results suggested that large cell
to cell variations in p53 dynamics were evident.
2.3. The MDM2 level controls bimodal switch of p53 dynamics
Chen et al. found that MDM2 downregulation may change the
dynamical mode of p53. We mimicked the MDM2 knockdown
condition in silico by setting dmdm2 = 0.5 (see reference parameter
value in Table 2) because mRNAs can be cleaved by RNA-induced
silencing complex (RISC) during RNAi process [23]. At 1 lMFig. 5. Heterogeneity in p53 pulses. (A) Stochastic runs classiﬁed as pulses were extracted
etoposide doses were shown in scatter plot. Standard deviations are shown in red bars. N
pulsing amplitude. (C) Scatter plot for pulsing period. Standard deviations are shown in re
CV for pulsing period.etoposide treatment, about 93% of cells underwent periodic puls-
ing under wild type conditions (Fig. 4). However, when MDM2
was knocked down, the system shifted the dynamical mode of
p53 from periodic pulses to 93.5% monotonic increasing (Fig. 6,
Figs. S3 and S4). Notably, both pulsing and monotonic increasing
dynamics are pronouncedly variable (Figs. S3 and S4).
Taken together, at high DNA damage levels, increased MDM2
phosphorylation may create a favorable environment for substan-
tially elevating p53 levels through multiple ways. Therefore, these
results suggested that differential MDM2 expression can strongly
inﬂuence the bimodal p53 dynamics.
2.4. Increased p53/MDM2 ratio may favor p53 cytoplasmic
localization
As previously identiﬁed, MDM2 can mediate both mono- and
poly-ubiquitination of p53 and the modiﬁcation status is largely
dependent on the relative stoichiometry [24]. Large abundance of
MDM2 over p53 favors poly-ubiquitination while lower amount
of MDM2 may promote mono-ubiquitination. Therefore, the rela-
tive ratio between p53 and MDM2 is critically important for the
subcellular localization of p53. Therefore, we integrated cellular
p53 and MDM2 levels at multiple etoposide doses. Then, the ratios
were quantiﬁed and the result was shown in Fig. 7. Note that the
bottom red blunted lines denote the mean values while the differ-
ence between the top and bottom lines represent standard devia-
tions (Fig. 7). For most cells treated with 65 lM etoposide, most
cells harbored a p53/MDM2 ratio less than 1 and for those treated
with 25 lM or higher, most ratios were beyond 2. For doses be-
tween 5 lM and 25 lM, the dominant species ﬂuctuated signiﬁ-
cantly among individual cells. Marchenko et al. showed that the
molar ratio of p53 to MDM2 determines the ubiquitination status.
When p53/MDM2 ratios are 1:2 or 1:1, cells may favor p53 desta-
bilization and degradation, while 2:1 or higher may results in p53
mono-ubiquitination and cytoplasmic translocation [24]. Chenand amplitudes were obtained. The amplitudes of the individual runs with different
ote that the means are shown as dots between top and bottom red bars. (B) CV for
d bars. Note that the means are shown as dots between top and bottom red bars. (D)
Table 1
Ordinary differential equations.
dp53
dt
¼ sp53  dp53  p53 rf  p53 MDM2pþ rb  p53MDM2p ð1Þ
dmdm2
dt
¼ smdm2  dmdm2 mdm2þ e1  P53pðt  s1Þ
4
P53pðt  s1Þ4 þ K4m
ð2Þ
dwip1
dt
¼ swip1  dwip1 wip1þ e2  P53pðt  s2Þ
4
P53pðt  s2Þ4 þ K4w
ð3Þ
dP53
dt
¼ rp53  p53þ rcomplex  p53MDM2p lP53  P53 k1 MDM2  P53
 katm1  ATM  P53þ kWIP1  P53p WIP1 ð4Þ
dP53p
dt
¼ katm1  ATM  P53 kWIP1  P53p WIP1 k2 MDM2  P53p ð5Þ
dMDM2
dt
¼ rmdm2 mdm2ðt  s3Þ  lMDM2 MDM2 katm2 MDM2  ATM
þ kWIP2 MDM2p WIP1 ð6Þ
dMDM2p
dt
¼ katm2 MDM2  ATM  kWIP1 MDM2p WIP1 lMDM2p MDM2p
 rf  p53 MDM2pþ rb  p53MDM2p ð7Þ
dWIP1
dt
¼ rwip1 wip1ðt  s4Þ  lWIP1 WIP1 ð8Þ
dATM
dt
¼ kAgent  ATM þ kauto  ATM  ATM  kWIP3 WIP1  ATM  kbasal
 ATM ð9Þ
dp53MDM2p
dt
¼ rf  p53 MDM2p rb  p53MDM2p ð10Þ
ATM þ ATM ¼ 1 lM; kAgent ¼ ka  ETSETSþ KAgent
Letters in lowercase and italics (p53, mdm2, wip1) denote mRNA, while species in
uppercase represent proteins. ETS denotes Etoposide.
Table 2
Model parameters and description.
Parameters Description Valuea
[p53]0 Initial concentration P53 mRNA 0.2
[mdm2]0 Initial concentration of MDM2 mRNA 0.1
[wip1]0 Initial concentration of WIP1 mRNA 0.02
[P53]0 Initial concentration of P53 0.0008
[MDM2]0 Initial concentration of MDM2 0.5882
[WIP1]0 Initial concentration of WIP1 0.0040
[ATM] Unphosphorylated ATM 1
sp53 Production rate of P53 mRNA 0.0005
smdm2 Production rate of MDM2 mRNA 0.001
swip1 Production rate of WIP1 mRNA 0.0005
dp53 Degradation rate of P53 mRNA 0.0025
dmdm2 Degradation rate of MDM2 mRNA 0.01
dwip1 Degradation rate of WIP1 mRNA 0.025
rp53 Translation rate of P53 0.005
rmdm2 Translation rate of MDM2 0.1
rwip1 Translation rate of WIP1 0.01
lP53 Degradation rate of P53 0.017
lMDM2 Degradation rate of MDM2 0.017
lMDM2p Degradation rate of MDM2p 0.135
lWIP1 Degradation rate of WIP1 0.005
e1 P53 dependent mdm2 transcription rate 0.005
e2 P53 dependent wip1 transcription rate 0.008
k1 MDM2 dependent P53 degradation 2
k2 MDM2 dependent P53p degradation 0.02
katm1 ATM⁄ induced P53 phosphorylation 3.5
katm2 ATM⁄ induced MDM2 phosphorylation 0.4
kwip1 WIP1 induced P53p dephosphorylation 0.25
kwip2 WIP1 induced MDM2p dephosphorylation 0.5
ka DSB induced ATM activation rate 0.025
kauto ATM autoactivation rate 0.005
kwip3 WIP1 induced ATM⁄ dephosphorylation 0.25
kbasal ATM⁄ basal inactivation rate 0.005
Km EC50 for mdm2 induced transcription 0.25
Kw EC50 for wip1 induced transcription 0.25
KAgent Activation scaling parameter 50
rf p53mRNA MDM2p association rate 0.5
rb p53–MDM2p dissociation rate 0.08
rcomplex p53–MDM2p translation rate 0.25
s1 mdm2 transcriptional delay 30
s2 wip1 transcriptional delay 30
s3 mdm2 translation delay 10
s4 wip1 translation delay 10
a The ﬁrst and second order rate constants are expressed in units of min1 and
lM1 min1, respectively. The production rates are expressed in units of lMmin1.
All delays take the unit min. Other initial conditions were set to zero.
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duced substantial accumulation of cytoplasmic p53 in contrast to
cells treated with 1 lM etoposide [21]. Our simulation data sug-
gested that increased p53 to MDM2 ratio at higher etoposide doses
may favor mono-ubiquitination and cytoplasmic p53 localization.
3. Discussion
We constructed a mathematical model that incorporated a re-
cently uncovered interaction between phosphorylated MDM2and p53 mRNA. In response to DNA damage, ATM can phosphory-
late MDM2 and Ser395 phosphorylated MDM2 can bind p53 mRNA
and stimulate translation. Evaluating a mutant model without cou-
pling this effect failed to resuscitate bimodal p53 dynamics
(Fig. S1). Using the whole model, we found that low etoposide
doses can trigger periodic p53 pulsing while p53 undergoes mono-
tonic increasing with high etoposide doses (Fig. 2). By stochastic
simulation, we further noticed that the dynamics of p53 varied
substantially either in pulsing or monotonic increasing mode
(Figs. 3–5). Lower damage doses may increase pulsing while cells
favor monotonic increasing at higher etoposide doses (Fig. 4). As
integrated p53 levels can be regarded as a cell fate determinant,
the non-monotone patterns may allow complex effects in cell fate
decision even in a deterministic manner. We also found that
MDM2 expression did exert pronounced control over the bimodal
switch of p53 dynamics as MDM2 knockdown may bias monotonic
increasing patterns (Fig. 6). As damage level increased, the ratio be-
tween p53 and MDM2 is signiﬁcantly upregulated (Fig. 7) and large
p53/MDM2 ratio is reported to favor MDM2 mediated mono-ubiq-
uitination and cytoplasmic translocation of p53 [24].
The ﬁndings that p53 may display bimodal dynamics at differ-
ent etoposide doses raise new challenges to the dynamical proper-
ties of p53 especially in cellular DNA damage responses. Since the
Fig. 7. p53/MDM2 ratios under different etoposide treatment. Flux was deﬁned as
the time integration of corresponding molecular species. P53: total p53. The
integration was calculated until 25 h. Data were represented in logarithm scale.
Bottom red bars: mean values. The difference between top and bottom horizontal
bars denotes standard deviations. Note that because standard deviations at 5 lM
and 10 lM etoposide are quite large and may bring about negative values in the
plot, and therefore can not be shown in logarithm scale.
Fig. 6. Fraction of p53 dynamical mode under MDM2 knocked-down condition.
Total 200 runs were performed by setting dmdm2 = 0.5. 13 out of 200 runs exhibited
oscillatory patterns.
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ics have posed growing concerns about how pulses are generated
[25–30] and how varying pulses per se can determine cell fate
[9–16]. Especially, when p53 digital pulses were uncovered,
numerous theoretical studies have demonstrated that the number
of pulses may tip the balance between survival and death. p53
pulses are triggered largely independent of DNA damage doses
while p53 network components may modulate the pulsing charac-
teristics through multiple ways. Instead, Zhang et al. then con-
structed ‘two-phase’ dynamic p53 models in which p53 may
either change pulsing period or increase to sustained high levels
(note that the high level is comparable to the pulsing peak) follow-
ing a series of initial pulses to describe a plausible cell fate decision
under severely stressed conditions [14,15]. A basic assumption in
these and some other models argues that activated p53 was distin-
guished as p53arrester and p53killer thereby implying promoter or
transcription speciﬁcity in p53 transcriptional network [14–16].
However, Kracikova et al. and Chen et al. experimentally showed
that p53 can activate both pro-arrest and pro-apoptotic gene
expression proportionally to induced p53 levels [21,22]. Therefore,
a threshold mechanism but not promoter speciﬁcity or pulsing fre-
quency should account for the cell fate decision. A few models,
however, showed that dynamical p53 responses might be bistable
either by incorporating PTEN-Akt pathways or BCL-2 family mem-
bers [18–20]. These theoretical studies may shed light on the
threshold mechanism but the existence of bistability in p53 system
remains to be experimentally deﬁned. The urgent need to unravel
the mechanisms of dynamical decision prompted a prominent
study in which Purvis et al. showed that a sustained over pulsingp53 may directly inﬂuence cell fate [31]. Noticeably, the drug
administered cells at precise time points might change the normal
cellular environment under stressed and unstressed conditions.
However, how dynamics of p53 determines cell fate is largely
undeﬁned.
Recently, Chen et al. experimentally revealed a novel mecha-
nism by which bimodal switch of p53 dynamics can dictate differ-
ent cell fates throughmodulating p53 levels [21]. Upregulating p53
at higher DNA damage while retaining physiological activities in
mild or unstressed conditions seems to be a more simple way to
dictate robust cell fates instead of pulse mediated decision possibly
because the p53 pulse is highly variable. However, several ques-
tions remain unresolved.
Through mathematical modeling, we found that incorporating
the effect of p53 mRNA and phosphorylated MDM2 binding can
reproduce the bimodal dynamics of p53 at least theoretically.
Meanwhile, by stochastic simulations we can partially characterize
the heterogeneity in the p53 dynamics both in pulsing and
monotonic increasing modes (Figs. 4 and 5). Although for certain
conditions (e.g., pulse height from 50 lM to 100 lM etoposide)
where small samples might lower the statistical power, the
random ﬂuctuation is evident irrespective of the etoposide doses
(Figs. 3–5).
In terms of MDM2p–p53mRNA binding and translation stimula-
tion, we should reconsider the effect of MDM2 in DNA damage re-
sponses [32,33]. Under non-stressed conditions, MDM2 may target
p53 for degradation to maintain low p53 levels and prevent detri-
mental effects of p53 overdose. Upon mild DNA damage induction,
p53 may upregulate mdm2 transcripts and mature MDM2 then
attenuate p53 levels via proteasome mediated degradation [34].
Systems with negative feedback loops are able to generate sus-
tained pulses [35]. However, as damage level increases, a signiﬁ-
cant fraction of MDM2 is transformed to phosphorylated forms.
The phosphorylated forms (MDM2p) may either undergo acceler-
ated degradation and attenuated p53 degradation or instead pro-
mote p53 mRNA translation and p53 induction [32,36]. Aided by
DNA damage sensor kinases, p53 induced MDM2 expression in-
stead poses a positive regulatory effect on its own production. Un-
der strong DNA damage, although the level of total MDM2 is
decreased compared with less stressed conditions (data not
shown), the translation stimulatory effect is substantially evident
and leads to massive p53 protein accumulation (Figs. 2–4) [32].
Therefore, p53 induced MDM2 expression and p53 translation
stimulation mediated by phosphorylated MDM2 may instead be-
come a plausible positive feedback loop at higher STS levels. To
some extent, the core p53–MDM2 network is intrinsically both
positively and negatively regulated and MDM2 can function as
both positive and negative regulator for p53 protein accumulation
via differential posttranslational modiﬁcations. The bipartite role
of MDM2 may explain why p53 protein is substantially accumu-
lated at higher DNA damage levels.
A critical issue is raised about whether the bimodal switch is ro-
bust. Sensitivity analysis showed that only explicit delays signiﬁ-
cantly affect the period while pulsing height is inﬂuenced by
multiple parameters. Meanwhile, we also found that WIP1 induc-
tion or degradation, mdm2 related reactions and p53mRNA–
MDM2p binding strongly inﬂuenced the sharpness of p53 eleva-
tion when STS level is high. Furthermore, we found that the bimo-
dal switch is relatively robust to parameter variations. Meanwhile,
changing catalytic reactions from mass action kinetics to Michae-
lis–Menten type also did not change the qualitative bimodal
dynamics (see Supplemental discussion for details). These results
imply that bimodal switch might be an intrinsic property in p53
mediated DNA damage response.
A further question remains about whether the current
system exhibits sharp or gradual transition between pulsing and
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tive feedback loops to make it more stable, while negative feedback
loops makes decision reversible [37]. Intrinsic positive effect may
allow a robust differential p53 accumulation with different etopo-
side doses as mutant model did not exhibit bimodal switch of p53
dynamics (Fig. S1). Meanwhile, two negative feedback loops may
instead give rise to heterogeneity in p53 dynamics classiﬁcation
and different cell fate. Therefore, the intricate architecture in
p53–MDM2 core network might per se allow a cell fate decision.
A bifurcation diagram is helpful. However, it could not be obtained
using DDE-BIFTOOL for unknown failures [38]. Preliminary going-
up and coming-down investigations instead showed that the
steady states did not elevate or decrease abruptly with varying
etoposide doses (data not shown) and thereby excluding the possi-
bility of bistability. Therefore, these results might infer a gradual
transition at least in our current model structure.
Noticeably, we did not rule out other dynamical mechanisms or
possibilities that can give rise to bimodal p53 induction. Incorpo-
rating other feedback loops especially positive feedback loops
may possibly help to shift gradual to an abrupt transition when
DNA damage is increased. In current model, we only evaluated
the effect of p53mRNA–MDM2p binding and suggested that this
newly identiﬁed interaction might contribute to a bimodal p53
induction. Detailed knowledge of larger network structure and
how it connects to core p53–MDM2 pathway is required to further
elucidate the bimodal mode of cell fate decision.4. Materials and methods
4.1. Biological background
Our model contains 10 species and 28 reactions. The core mod-
ule of current model is derived from our previous work [39]. For
p53, MDM2 and WIP1, we incorporated both mRNA and protein
species. We assume that etoposide which is a topoisomerase II
inhibitor and induces DNA double strand breaks (DSBs) can
phosphorylated and activate ATM which is consistent with the
experimental observations (Table 1) [40]. Total ATM (Ataxia-
telangiectasia mutated) was considered as a constant because
experiments showed that the level of ATM does not change signif-
icantly within 72 h [41]. Activated ATM can phosphorylate p53 and
MDM2 at speciﬁc sites [42,43]. The phosphorylated forms of p53
and MDM2 either become stabilized or destabilized with acceler-
ated degradation respectively [43,44]. Two core negative feedback
loops were considered in our model and no positive feedback loops
were incorporated as suggested by Lahav et al. [45]. The ﬁrst neg-
ative feedback loop involves p53 and MDM2. Under stressed con-
ditions, activated p53 can induce mdm2 expression and MDM2
in turn targets p53 for proteasome degradation. The second nega-
tive feedback loop involves p53, WIP1 and ATM (CHK2). Activated
ATM can phosphorylate and activate p53. As a result, phosphory-
lated p53 can upregulate WIP1 which functions as a phosphatase
and dephosphorylate CHK2, phosphorylated ATM, p53 and
MDM2. The levels of etoposide (ETS) denote model input and affect
the DNA damage induced activation rate of ATM (see parameter
kAgent in Eq. (9), Tables 1 and 2).
Gajjar et al. recently found that under conditions of genomic
stress, ATM can phosphorylate MDM2 at Ser395 and allosterically
changed MDM2 can bind p53 mRNA [32]. The MDM2 (i.e., Ser395
phosphorylated form) binding can stimulate p53mRNA translation
[32]. We incorporated this newly identiﬁed interaction in our mod-
el. We assumed that p53 mRNA can bind MDM2p and form a p53
mRNA–MDM2p complex. We also assume that this complex can
translate p53 proteins with higher efﬁciency (see thick arrows in
Fig. 1, Eqs. (1), (7), and (10) in Table 1). Note that our model didnot consider the subcellular localization of all species not only
for simplicity but also because the molecular mechanism by which
the transient MDM2-dependent nucleolar targeting of p53 mRNA
enhances its translation and its detailed subcellular trafﬁcking
events remain elusive [32,33]. Subcellular trafﬁcking will add an-
other layer of complexity and the detailed mechanistic model will
be investigated in future. All the kinetic reactions were schemati-
cally represented in Fig. 1. Thick arrows denote newly added reac-
tions compared with our original model [39]. All the dynamic
reactions were formulated using ordinary differential equations
(ODEs) (Table 1). All parameters can be found in Table 2.
4.2. Stochastic simulation
As the maximum levels of dynamic species are around the order
of 105, we performed stochastic simulations using a binomial delay
s-leap method according to Chatterjee et al. and Leier et al.’s algo-
rithm [46,47]. During the simulation, all delays (s1, s2, s3 and s4)
were varied by 10% of their reference values. In addition, we also as-
sumed that transcription occurs in burst and the size of bursts pos-
itively correlate with the amount of transcription factors [48].
Meanwhile, during each simulation, parameters of a single cell
was multiplied by a random number eXwhere X is normally distrib-
uted (XN(0, 0.1), KAgent and ETS doses are not similarly varied be-
cause these parameters denote the model input. See Table 2) [49].
4.3. Undamped pulses detection
To identify whether stochastic trajectories of total p53 (i.e.,
sums of phosphorylated and unphosphorylated forms) perform un-
damped pulses, the pitch detection method was used [49]. The sto-
chastic time course data were sampled as an interval of 0.5 min.
The autocorrelation of signals were calculated and if the autocorre-
lation value is higher than or equal to 0.2, the trajectory was re-
garded as performing undamped pulses. Also the period was
obtained from the detected pitch. The other trajectories were clas-
siﬁed as monotonic increasing patterns.
4.4. Model simulation
Delay differential equations were integrated using dde23 solver
embedded in MATLAB. Both deterministic and stochastic simula-
tions were performed using MATLAB (MathWork, Version
7.12.0.635, R2011a).
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